Matti Korhonen

4.0k citations
80 papers · 3.1k indexed · h-index 34

Matti Korhonen

79 papers receiving 3.0k citations

Peers

Matti Korhonen
Comparison fields: 5 of 115
  • Immunology and Allergy 786
  • Genetics 622
  • Obstetrics and Gynecology 218
  • Oncology 711
  • Hematology 288
Replace Sela Cheifetz with:
Sela Cheifetz United States
Jean Plouët France
Jean‐Michel Foidart Belgium
Naomi Fukai United States
Yamato Kikkawa Japan
Erika Gustafsson Sweden
Ole Behrendtsen United States
Nancy Boudreau United States
W. Scott Argraves United States
Ichiro Naito Japan
Matti Korhonen relative to Sela Cheifetz United States Sela Cheifetz's profile →
Citations per field
00.5×3.6×
Sela Cheifetz · 1×
Citations per year

Countries citing papers authored by Matti Korhonen

Since Specialization
Citations

This map shows the geographic impact of Matti Korhonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Korhonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Korhonen more than expected).

Fields of papers citing papers by Matti Korhonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Korhonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Korhonen. The network helps show where Matti Korhonen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Matti Korhonen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matti Korhonen Line = papers co-authored together Matti Korhonen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 20239
3 20225
4 2019157
5 20198
6 201945
7 201912
8 201816
9 201713
10 201651
11 20121
12 201265
13 201265
14 201211
15 200912
16 200924
17 200561
18 200032
19 199738
20 199237

About Matti Korhonen

Matti Korhonen is a scholar working on Immunology and Allergy, Genetics and Hematology, having authored 80 papers that have together received 3.1k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (20 papers), Cell Adhesion Molecules Research (18 papers), Hematopoietic Stem Cell Transplantation (12 papers), Tissue Engineering and Regenerative Medicine (9 papers), CAR-T cell therapy research (7 papers), Cancer Cells and Metastasis (5 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Periodontal Regeneration and Treatments (5 papers). The work is most often cited by research in Immunology and Allergy (786 citations), Genetics (622 citations) and Obstetrics and Gynecology (218 citations). Matti Korhonen has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Ismo Virtanen, L. Laitinen, Jari Ylänne, Johanna Nystedt, Victor E. Gould, George Κ. Koukoulis, Saara Laitinen, Petri Lehenkari, Vito Quaranta and Mika Hukkanen. Their work appears in journals such as Journal of Histochemistry & Cytochemistry, Cytotherapy, Stem Cell Research & Therapy, Bone Marrow Transplantation and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026